Burning Rock Biotech Limited
BNR
$4.60
-$0.10-2.13%
| 03/31/2024 | 12/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 4.34% | -4.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.34% | -4.78% | |||
| Cost of Revenue | -6.55% | 3.51% | |||
| Gross Profit | 10.33% | -8.80% | |||
| SG&A Expenses | -14.56% | -5.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.01% | -5.90% | |||
| Operating Income | 23.92% | 6.69% | |||
| Income Before Tax | 24.25% | 7.38% | |||
| Income Tax Expenses | -83.07% | 138.81% | |||
| Earnings from Continuing Operations | 24.64% | 7.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.64% | 7.01% | |||
| EBIT | 23.92% | 6.69% | |||
| EBITDA | 29.95% | 9.92% | |||
| EPS Basic | 24.75% | 7.07% | |||
| Normalized Basic EPS | 24.36% | 7.45% | |||
| EPS Diluted | 24.75% | 7.07% | |||
| Normalized Diluted EPS | 24.36% | 7.45% | |||
| Average Basic Shares Outstanding | 0.14% | 0.07% | |||
| Average Diluted Shares Outstanding | 0.15% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
